{"id":"W4389130660","doi":"10.1136/jitc-2023-007353","title":"Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors","year":2023,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Rash; Adverse effect; Internal medicine; Cohort; Colorectal cancer; Lung cancer; Monoclonal antibody; Gastroenterology; Antibody; Cancer; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001585676,0.00158707,0.001814594,0.0004116202,0.0004069564,0.0008168844,0.0008066377,0.0009237662,0.002097877],"category_scores_gemma":[0.0007164747,0.0005888467,0.001183051,0.0004020986,0.001194078,0.0009220616,0.0004098083,0.003260834,0.0006243486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001097835,"about_ca_system_score_gemma":0.001599725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009068871,"about_ca_topic_score_gemma":0.00173904,"domain_scores_codex":[0.9995666,0.0001863099,0.00002558825,0.00008190607,0.00004210706,0.00009747089],"domain_scores_gemma":[0.9992967,0.00008690181,0.0001413025,0.00007425276,0.00005324922,0.0003476642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6945888,0.1395372,0.009622504,0.0006205274,0.001326479,0.0002560167,0.0005875951,0.003550482,0.06377431,0.0002496325,0.00338014,0.08250634],"study_design_scores_gemma":[0.4047242,0.5772629,0.009473066,0.00001954247,0.0002856819,0.0002407594,0.00007211589,0.001155469,0.004865848,0.0001592531,0.00171858,0.00002267642],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961805,0.0009104931,0.0004318783,0.0002271567,0.00006331817,0.001055758,0.0003845428,0.00006485039,0.0006815001],"genre_scores_gemma":[0.9933222,0.0009052501,0.001353467,0.0005282831,0.0001149194,0.001349974,0.001093381,0.00002214681,0.001310325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002097877,"threshold_uncertainty_score":0.008385956,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01604813275007517,"score_gpt":0.3554961998091867,"score_spread":0.3394480670591116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}